Investors & Media

SEC Filing Details

Document Details

Form
Filing Date
Feb 12, 2020
Document Date
Dec 31, 2019
Form Description
Annual filing director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Sangamo Therapeutics, Inc.
Issuer
SANGAMO THERAPEUTICS, INC
Filer
Boissel Stephane